Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations.

Wateska, Angela R

Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations. [electronic resource] - American journal of preventive medicine 04 2020 - 487-495 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

1873-2607

10.1016/j.amepre.2019.10.022 doi


Black or African American--statistics & numerical data
Aged
Aged, 80 and over
Cost-Benefit Analysis
Female
Humans
Male
Markov Chains
Pneumococcal Infections--economics
Pneumococcal Vaccines--administration & dosage
Quality-Adjusted Life Years
United States
Vaccination--economics
Vaccines, Conjugate--administration & dosage